Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Comprehensive analysis of ID genes reveals the clinical and prognostic value of ID3 expression in acute myeloid leukemia using bioinformatics identification and experimental validation

Fig. 3

The associations of ID3 expression with cytogenetic risks/genetic abnormalities in AML. a ID3 expression among different cytogenetic risks of AML. b ID3 expression in AML patients with and without FLT3 mutations. c ID3 expression in AML patients with and without NPM1 mutations. d ID3 expression in AML patients with and without CEBPA mutations. e ID3 expression in AML patients with and without TP53 mutations

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us